Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003095753 | SCV003485529 | benign | Nemaline myopathy 2 | 2024-03-03 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003134652 | SCV003810264 | uncertain significance | not provided | 2020-09-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003269455 | SCV003950010 | uncertain significance | Inborn genetic diseases | 2023-04-06 | criteria provided, single submitter | clinical testing | The c.6827G>T (p.W2276L) alteration is located in exon 52 (coding exon 50) of the NEB gene. This alteration results from a G to T substitution at nucleotide position 6827, causing the tryptophan (W) at amino acid position 2276 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |